Ostrosky-Zeichner L - Search Results

1

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis.

Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. Jaijakul S, et al. Clin Infect Dis. 2012 Aug;55(4):521-6. doi: 10.1093/cid/cis456. Epub 2012 May 9. Clin Infect Dis. 2012. PMID: 22573851 Clinical Trial.

2

Deeply invasive candidiasis.

Ostrosky-Zeichner L, Rex JH, Bennett J, Kullberg BJ. Ostrosky-Zeichner L, et al. Infect Dis Clin North Am. 2002 Dec;16(4):821-35. doi: 10.1016/s0891-5520(02)00034-x. Infect Dis Clin North Am. 2002. PMID: 12512183 Review.

3

Amphotericin B: time for a new "gold standard".

Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH. Ostrosky-Zeichner L, et al. Clin Infect Dis. 2003 Aug 1;37(3):415-25. doi: 10.1086/376634. Epub 2003 Jul 22. Clin Infect Dis. 2003. PMID: 12884167

4

Voriconazole salvage treatment of invasive candidiasis.

Ostrosky-Zeichner L, Oude Lashof AM, Kullberg BJ, Rex JH. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):651-5. doi: 10.1007/s10096-003-1014-3. Epub 2003 Oct 17. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14564539

5

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome.

Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. Odabasi Z, et al. Clin Infect Dis. 2004 Jul 15;39(2):199-205. doi: 10.1086/421944. Epub 2004 Jun 28. Clin Infect Dis. 2004. PMID: 15307029

6

Prophylaxis and treatment of invasive candidiasis in the intensive care setting.

Ostrosky-Zeichner L. Ostrosky-Zeichner L. Eur J Clin Microbiol Infect Dis. 2004 Oct;23(10):739-44. doi: 10.1007/s10096-004-1215-4. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15372315 Review.

7

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans.

Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MA, Rex JH. Ostrosky-Zeichner L, et al. Clin Infect Dis. 2005 Sep 1;41(5):654-9. doi: 10.1086/432470. Epub 2005 Jul 21. Clin Infect Dis. 2005. PMID: 16080087

8

Invasive candidiasis in immunocompromised hospitalized patients.

Sims CR, Ostrosky-Zeichner L, Rex JH. Sims CR, et al. Arch Med Res. 2005 Nov-Dec;36(6):660-71. doi: 10.1016/j.arcmed.2005.05.015. Arch Med Res. 2005. PMID: 16216647 Review.

9

International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.

Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. doi: 10.1007/s10096-005-0024-8. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16261306 Clinical Trial.

10

Invasive candidiasis in the intensive care unit.

Ostrosky-Zeichner L, Pappas PG. Ostrosky-Zeichner L, et al. Crit Care Med. 2006 Mar;34(3):857-63. doi: 10.1097/01.CCM.0000201897.78123.44. Crit Care Med. 2006. PMID: 16505666 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters